Cutaneous angiosarcoma treated with taxane‐based chemoradiotherapy: A multicenter study of 90 Japanese cases

Cutaneous angiosarcoma (CAS) is rare and most previous studies of CAS have been small case series, and randomized, phase II studies of CAS are limited. Since treatment options for CAS are controversial, and because only paclitaxel should be recommended based on high‐level evidence, it is important t...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimura, Taku, Furudate, Sadanori, Maekawa, Takeo, Kato, Hiroshi, Ito, Takamichi, Matsushita, Shigeto, Yoshino, Koji, Hashimoto, Akira, Muto, Yusuke, Ohuchi, Kentaro, Amagai, Ryo, Kambayashi, Yumi, Fujisawa, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892413/
https://www.ncbi.nlm.nih.gov/pubmed/36751323
http://dx.doi.org/10.1002/ski2.180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892413/
https://www.ncbi.nlm.nih.gov/pubmed/36751323
http://dx.doi.org/10.1002/ski2.180

Ejemplares similares